Search Tag: Bayer

IT Management

2024 09 Apr

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear...Read more

IMAGING Management

2024 09 Apr

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear...Read more

Artificial Intelligence

2024 09 Apr

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear...Read more

IMAGING Management

2024 22 Jan

Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich, Member of the Board of Management, Bayer AG, and President Pharmaceuticals. Ambrogio will serve on the Pharmaceuticals Executive Committee and be based in Berlin, Germany. Gerd Krueger,...Read more

Executive Health Management

2023 08 Jun

New Consumer Health North America President, U.S. CFO and Head of North America Diversity, Equity & Inclusion   Bayer, one of the country’s leading life-sciences companies announced changes to its U.S. Country Leadership Team.   Dave Tomasi will be the  President, Consumer Health North America (CH NA), effective July 1.  Dave, who has...Read more

IMAGING Management

2023 02 Mar

The future of medical imaging and the role of AI: Bayer reinforces commitment to innovation in Radiology Focus on artificial intelligence (AI) and its potential to address key challenges in radiology today Education and training are key to enable an effective adoption of AI Building on a deep medical expertise, Bayer is driving innovation in...Read more

IMAGING Management

2023 22 Feb

Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), taking place from...Read more

IMAGING Management

2023 13 Feb

Closing follows announcement of acquisition on January 18, 2023 Acquisition bolsters Bayer’s position in digital medical imaging Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer announced that the company has completed the acquisition of the global strategic...Read more

IMAGING Management

2023 18 Jan

Acquisition is part of Bayer’s innovation strategy in radiology Blackford Analysis provides cutting-edge radiology AI (artificial intelligence) platform technology Following closing of the acquisition, Blackford Analysis to become part of Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture...Read more

IMAGING Management

2022 28 Jun

AI applications for medical imaging can improve prioritization, lesion detection,quantification and productivity Cloud-hosted platform provides access to AI applications* that integrate into standard medical imaging workflow Market introduction to start in US and several European countries Strategically complements Bayer’s comprehensive portfolio...Read more

IMAGING Management

2015 14 Jul

Approval based on data demonstrating the pharmacokinetic and safety profiles of Gadovist at standard dose (0.1 mmol/kg) were similar to adults and children 2 years of age and older Diagnostic use in approved indications has been expanded to include use in pediatric patients less than 2 years of age, including term newborns New expanded use...Read more